Skip to main content
logo
Imugene Limited (ASX:IMU)
Australia flag Australia · Delayed Price · Currency is AUD
0.2900
-0.0150 (-4.92%)
Jan 30, 2026, 11:21 AM AEST

Imugene Revenue

In the fiscal year ending June 30, 2025, Imugene had annual revenue of 4.40M AUD, down -11.53%. Imugene had revenue of 3.14M in the half year ending June 30, 2025, a decrease of -54.94%.

Revenue
4.40M
Revenue Growth
-11.53%
P/S Ratio
22.18
Revenue / Employee
879.36K
Employees
5
Market Cap
97.53M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20254.40M-573.22K-11.53%
Jun 30, 20244.97M-6.81M-57.80%
Jun 30, 202311.78M-1.19M-9.19%
Jun 30, 202212.97M5.74M79.35%
Jun 30, 20217.23M3.10M74.94%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
EZZ Life Science Holdings66.87M
Radiopharm Theranostics12.51M
Starpharma Holdings5.85M
Alterity Therapeutics5.44M
Prescient Therapeutics4.36M
Arovella Therapeutics3.44M
Proteomics International Laboratories3.31M
Cynata Therapeutics1.89M
Revenue Rankings

Imugene News

More News